PreprintAll rights reservedbioRxiv
DNA Methylation Drives Aberrant Osteochondrogenesis in Keloid and Is Reversible by Decitabine
- 1Dermatology Hospital, Southern Medical University
Related
- Tumour-stroma signaling drives a reversible program with neural-like features in cancer-associated fibroblasts
- IL-1β/IL-6 inflammatory crosstalk drives DNA methylation and histone remodeling associated with cytokine induced senescence in luminal breast cancer.
- A comparison of overall survival and quality of life in patients with MDS treated with azacytidine vs decitabine.
- Epigenetic Priming with Oral Decitabine/Cedazuridine Combined with Nivolumab in Unresectable or Metastatic Mucosal Melanoma: Clinical and Correlative Findings from a Phase Ib/II Trial.
- Overestimated Volatility Underpins Aberrant Decision Making in Bipolar I Disorder
BibTeX
@misc{li2026methylation,
title = {{DNA Methylation Drives Aberrant Osteochondrogenesis in Keloid and Is Reversible by Decitabine}},
author = {H. Li and L. Zhang and C. Liu and X. Zhou and Z. Yan and R. He and Z. Li and S. Zhao and C. Deng and B. Yang},
howpublished = {bioRxiv},
year = {2026},
month = aug,
doi = {10.64898/2026.08.26.747276},
url = {https://www.biorxiv.org/content/10.64898/2026.08.26.747276v1},
}
RIS
TY - UNPB
TI - DNA Methylation Drives Aberrant Osteochondrogenesis in Keloid and Is Reversible by Decitabine
AU - H. Li
AU - L. Zhang
AU - C. Liu
AU - X. Zhou
AU - Z. Yan
AU - R. He
AU - Z. Li
AU - S. Zhao
AU - C. Deng
AU - B. Yang
PY - 2026
DA - 2026/08/26
PB - bioRxiv
DO - 10.64898/2026.08.26.747276
UR - https://www.biorxiv.org/content/10.64898/2026.08.26.747276v1
ER -